Rat precision-cut liver slices predict drug-induced cholestatic injury.
- Published in:
- Archives of Toxicology, 2017, v. 91, n. 10, p. 3403, doi. 10.1007/s00204-017-1960-7
- By:
- Publication type:
- Article
Works by Ghimire, Samiksha
Results: 7
1
2
Therapeutic drug monitoring in patients with tuberculosis and concurrent medical problems.
- Published in:
- Expert Opinion on Drug Metabolism & Toxicology, 2021, v. 17, n. 1, p. 23, doi. 10.1080/17425255.2021.1836158
- By:
- Publication type:
- Article
3
Linezolid-based Regimens for Multidrug-resistant Tuberculosis (TB): A Systematic Review to Establish or Revise the Current Recommended Dose for TB Treatment.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, p. S327, doi. 10.1093/cid/ciy625
- By:
- Publication type:
- Article
4
Amikacin Dosing for MDR Tuberculosis: A Systematic Review to Establish or Revise the Current Recommended Dose for Tuberculosis Treatment.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, p. S303, doi. 10.1093/cid/ciy613
- By:
- Publication type:
- Article
5
Pharmacokinetic/pharmacodynamic-based optimization of levofloxacin administration in the treatment of MDR-TB.
- Published in:
- 2016
- By:
- Publication type:
- journal article
6
Dried Blood Spot Sampling to Assess Rifampicin Exposure and Treatment Outcomes among Native and Non-Native Tuberculosis Patients in Paraguay: An Exploratory Study.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 4, p. 1089, doi. 10.3390/pharmaceutics15041089
- By:
- Publication type:
- Article
7
Safety of Rifampicin at High Dose for Difficult-to-Treat Tuberculosis: Protocol for RIAlta Phase 2b/c Trial.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 1, p. 9, doi. 10.3390/pharmaceutics15010009
- By:
- Publication type:
- Article